<DOC>
	<DOCNO>NCT00898677</DOCNO>
	<brief_summary>A study compare rizatriptan 10 mg verse sumatriptan 100 mg treatment migraine attack duration relief provide . This study also provide additional efficacy data rizatriptan 5 mg 10 mg treatment migraine .</brief_summary>
	<brief_title>Rizatriptan 5 mg 10 mg , Sumatriptan 100 mg , Placebo Comparison Study ( 0462-030 )</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Patient least 6month history migraine , without aura Patient male , female must postmenopausal , surgically sterilize , take adequate contraceptive precaution . Patient judge good health , apart migraine Patient pregnant nursing mother Patient abuse drug alcohol within 12 month prior enter study Patient history cardiovascular disease Patient clinically significant Electrocardiography ( ECG ) abnormality Patient rest systolic blood pressure great 145 mm Hg diastolic le 95 mm Hg screening Patient receive treatment investigational device compound within 30 day study start Patient typically suffer less 1 8 attack migraine per month Patient difficulty distinguish his/her migraine attack tension interval headache Patient hypersensitivity sumatriptan Patient participate previous study involve rizatriptan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>